Amylyx Pharmaceuticals, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2021 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Amylyx Pharmaceuticals, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2021 to Q2 2024.
  • Amylyx Pharmaceuticals, Inc. Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2024 was $2.77M, a 40.4% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $2.77M -$1.87M -40.4% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $3.25M -$1.84M -36.1% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $3.73M -$1.8M -32.6% Dec 31, 2023 10-Q 2024-08-08
Q3 2023 $4.19M -$1.76M -29.6% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $4.64M -$1.73M -27.1% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $5.09M -$1.7M -25% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $5.52M +$524K +10.5% Dec 31, 2022 10-K 2024-02-22
Q3 2022 $5.95M Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $6.37M Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $6.79M Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $5M Jan 10, 2022 10-K 2024-02-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.